Patent foramen ovale (PFO) closure method and device
Summary by NHIP
PFO closure device and method
The method closes septum primum and septum secundum by inserting a device into the right atrium, puncturing septum primum, and then puncturing septum secundum with the device's first end. Distinctive steps include embedding the first end within septum secundum without extending through it or completely puncturing septum secundum to extend the first end into the right atrium.
Claim Score by NHIP
Abstract
The present invention provides methods and devices for closing two overlapping layers of tissue in a mammalian heart, for example a patent foramen ovale (PFO). The closure devices may take a number of different forms and may be retrievable. In some embodiments, the closure devices may be delivered with a catheter capable of puncturing mammalian tissue.

Term
Term ended
Expired 3 January 2025, 1.7 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
29 claims: 1 independent, 28 dependent
- 1Broadest claimClaim Score 55, average(NHIP)A method of closing septum primum and septum secundum in a mammalian heart, comprising:(a) inserting a closure device into a right atrium of said heart, said device including first and second ends;(b) puncturing septum primum and passing said first end of said first end of said closure device through septum primum into a left atrium of said heart;(c) puncturing septum secundum with said first end of said closure device after said closure device has passed through septum primum;and (d) positioning said second end of said closure device against septum secundum in the right atrium such that said closure device provides a compressive force to compress at least one of septum primum and septum secundum therebetween.
45 paragraphs in 4 sections, as filed
BACKGROUND OF THE INVENTION
A patent foramen ovale (PFO) as shown in <figref idref="DRAWINGS">FIG. 1</figref>, is a persistent, one-way, usually flap-like opening in the wall between the right atrium <b>10</b> and left atrium <b>12</b> of the heart. Since left atrial (LA) pressure is normally higher than right atrial (RA) pressure, the flap typically stays closed. Under certain conditions, however, RA pressure can exceed LA pressure creating the possibility for right to left shunting that can allow blood clots to enter the systemic circulation. In utero, the foramen ovale serves as a physiologic conduit for right-to-left shunting. After birth, with the establishment of pulmonary circulation, the increased left atrial blood flow and pressure results in functional closure of the foramen ovale. This functional closure is subsequently followed by anatomical closure of the two over-lapping layers of tissue: septum primum <b>14</b> and septum secundum <b>16</b>. However, a PFO has been shown to persist in a number of adults.
The cause of ischemic stroke remains cryptogenic (of unknown origin) in approximately 40% of cases. Especially in young patients, paradoxical embolism via a PFO is considered in the diagnosis. While there is currently no proof for a cause-effect relationship, many studies have confirmed a strong association between the presence of a PFO and the risk for paradoxical embolism or stroke. In addition, there is good evidence that patients with PFO and paradoxical embolism are at increased risk for future, recurrent cerebrovascular events.
The presence of a PFO has no therapeutic consequence in otherwise healthy adults. In contrast, patients suffering a stroke or transient ischemic attack (TIA) in the presence of a PFO and without another cause of ischemic stroke are considered for prophylactic medical therapy to reduce the risk of a recurrent embolic event. These patients are commonly treated with oral anticoagulants, which have the potential for adverse side effects, such as hemorrhaging, hematoma, and interactions with a variety of other drugs.
In certain cases, such as when anticoagulation is contraindicated, surgery may be used to close the PFO. To suture a PFO closed requires attachment of septum secundum to septum primum with either an interrupted or a continuous stitch, which is the common way a surgeon shuts the PFO under direct visualization.
Nonsurgical closure of PFOs has become possible with the advent of umbrella devices and a variety of other similar mechanical closure designs, developed initially for percutaneous closure of atrial septal defects (ASD). These devices allow patients to avoid the potential side effects often associated with anticoagulation therapies.
Currently available designs of septal closure devices, however, present such drawbacks as technical complexity of implantation procedure, high complication rates (thrombus, fractures, conduction system disturbances, perforations, residual leaks), high septal profile, large masses of foreign material, and lack of anatomic conformability especially to the PFO flap-like anatomy, as most were originally designed to close ASD's, which are true holes. Additionally, some septal closure devices are complex to manufacture, which can result in lack of consistency in product performance.
SUMMARY OF THE INVENTION
In one aspect, the present invention provides a method of closing two overlapping layers of tissue in a mammalian heart, e.g., a patent foramen ovale (PFO), using a closure device that applies a compressive force to at least one of the layers of tissue. The closure device may be retrievable, such that it may be removed after a period of time sufficient to allow the overlapping layers of tissue to fuse together. If necessary to sufficiently close the length of the layers of tissue, multiple closure devices may be administered. The closure devices may be delivered with a catheter capable of puncturing mammalian tissue in at least one location.
The closure device of the present invention may take a number of different forms. For example, the closure device may have first and second ends, both of which may be capable of puncturing mammalian tissue. The device may be a structure such as a ring with a gap, a folded ring, at least one grappling hook member joined to at least one curved arm by a joinder member, opposed grappling hook members joined by a central connecting member, a grappling hook member and a central connecting member, or a closure device anchor joined to a structure of sufficient diameter to hold the device in place against the overlapping layers of tissue. In some embodiments of the present invention, the closure device is sized and shaped such that it extends from septum secundum in the left atrium, into the left atrium, through septum primum, into the right atrium, and to septum secundum in the right atrium. Some retrievable devices include elongate tethers to facilitate their removal. Each of these devices has certain advantages, and one skilled in the art will be capable of selecting the device appropriate for a given application.
The ends of the closure device may also take a number of different forms. For example, at least one end may form a disc or a closure device anchor, such as a coil, hook, or corkscrew. These end structures help to maintain the device in place. One of the ends, for example the second end, may take the form of a knot or a structure similarly capable of holding the device in place and applying a sufficient compressive force to the overlapping layers of tissue. In some embodiments, the end structure may be adjusted to alter the compressive force applied to the overlapping layers of tissue. As previously mentioned, either or both of the first and second ends may be capable of puncturing mammalian tissue. In some embodiments, the first end of the device is a septal puncture needle.
The closure device may be formed of any of several materials, such as flexible polymer materials, bioabsorbable materials, shape memory materials, metals, noble metals, or swellable foams. In particular embodiments, the device includes nitinol. Some of the devices are formed from a single piece of material, while others are formed from multiple pieces of material joined together.
Some closure devices according to the present invention are intended to puncture septum primum upon insertion into the heart. For example, such a device may be inserted into the right atrium of the heart and puncture septum primum to enter the left atrium of the heart. At this point, the first end of the device may simply be deployed into the left atrium, or the first end of the device may be deployed into the left atrium and at least partially puncture septum secundum. In those embodiments where the first end of the device at least partially punctures septum secundum, the first end may be embedded in septum secundum or may completely puncture septum secundum such that the first end extends into the right atrium. The second end of the device may then be positioned against septum secundum in the right atrium, thereby providing a compressive force to the septal tissues. In other embodiments, the second end is also positioned in the left atrium while another portion of the device, such as a fold, is positioned in the right atrium, thereby compressing the septal tissues between the device.
Alternatively, some closure devices according to the present invention are intended to be inserted between the overlapping layers of tissue, e.g. through the PFO tunnel, to enter the left atrium. In these embodiments, the first end of the device is then deployed in the left atrium and the second end of the device is deployed in the right atrium, thereby providing a compressive force to the septal tissue. As discussed above, at least one of the ends of the device may partially puncture septum secundum.
These and other features will become readily apparent from the following detailed description wherein embodiments of the invention are shown and described by way of illustration.
BRIEF DESCRIPTION OF THE DRAWINGS
<figref idref="DRAWINGS">FIG. 1</figref> is a diagrammatic sectional view of a Patent Foramen Ovale (PFO);
<figref idref="DRAWINGS">FIG. 2</figref> is a view in side elevation of the PFO closure device with mechanical anchors of the present invention;
<figref idref="DRAWINGS">FIGS. 3</figref><i>a</i>, <b>3</b><i>b </i>and <b>3</b><i>c </i>illustrate the steps in the deployment of the PFO closure device of <figref idref="DRAWINGS">FIG. 2</figref>;
<figref idref="DRAWINGS">FIG. 4</figref> is a view in side elevation of a second embodiment of the PFO closure device with mechanical anchors of the present invention;
<figref idref="DRAWINGS">FIGS. 5</figref><i>a</i>, <b>5</b><i>b </i>and <b>5</b><i>c </i>illustrate the steps in the deployment of the PFO closure device of <figref idref="DRAWINGS">FIG. 4</figref>;
<figref idref="DRAWINGS">FIG. 6</figref> is a view in side elevation of a catheter and septal puncture needle used to pierce septum primum;
<figref idref="DRAWINGS">FIG. 7</figref> is a view in side elevation of a needle anchor for PFO closure;
<figref idref="DRAWINGS">FIG. 8</figref> is a view in side elevation of a suture and anchor used for PFO closure;
<figref idref="DRAWINGS">FIG. 9</figref> is a diagram of multiple anchor placement for PFO closure;
<figref idref="DRAWINGS">FIGS. 10</figref><i>a</i>, <b>10</b><i>b </i>and <b>10</b><i>c </i>illustrate the steps in the deployment of a rivet and suture type of PFO closure device;
<figref idref="DRAWINGS">FIGS. 11</figref><i>a</i>, <b>11</b><i>b</i>, <b>11</b><i>c </i>and <b>11</b><i>d </i>illustrate the steps in the deployment of a removable PFO closure device;
<figref idref="DRAWINGS">FIGS. 12</figref><i>a</i>, <b>12</b><i>b </i>and <b>12</b><i>c </i>illustrate the steps in the deployment of a multiple hook PFO closure device;
<figref idref="DRAWINGS">FIG. 13</figref> is a view in side elevation of an alternative structure of the second embodiment of the PFO closure device with mechanical anchors of the present invention;
<figref idref="DRAWINGS">FIG. 14</figref> is a view in side elevation of an alternative structure of the second embodiment of the PFO closure device with mechanical anchors of the present invention; and
<figref idref="DRAWINGS">FIGS. 15</figref><i>a</i>, <b>15</b><i>b</i>, and <b>15</b><i>c </i>are an end face view from the right atrium, an end face view from the left atrium, and a side elevation view, respectively, of the deployed alternative structure of the second embodiment of the PFO closure device with mechanical anchors of the present invention.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
Referring to <figref idref="DRAWINGS">FIGS. 2 and 3</figref>, a PFO closure device with mechanical anchors indicated generally at <b>18</b> includes opposed grappling hook members <b>20</b> and <b>22</b> connected by a central connecting member <b>24</b>. When the PFO closure device <b>18</b> is deployed, the grappling hook members <b>20</b> and <b>22</b> each include two or more curved hooks. In <figref idref="DRAWINGS">FIGS. 2 and 3</figref>, three curved hooks <b>26</b>, <b>28</b> and <b>30</b> form the grappling hook member <b>20</b> and three curved hooks <b>32</b>, <b>34</b> and <b>36</b> form the grappling hook member <b>22</b>. As shown in <figref idref="DRAWINGS">FIG. 2</figref>, the grappling hooks <b>26</b>, <b>28</b>, <b>30</b>, <b>32</b>, <b>34</b>, and <b>36</b> extend radially from the central connecting member <b>24</b>. The grappling hooks of grappling hook members <b>20</b> and <b>22</b> have the same geometry but are rotated such that each grappling hook of grappling hook member <b>20</b> is situated precisely between two opposed grappling hooks of grappling hook member <b>22</b>. The angle between any two grappling hooks of grappling hook members <b>20</b> and <b>22</b> may be determined by the formula 360°/(number of hooks per grappling hook member). To fit within a catheter, these hooks may all be straightened outwardly and compressed to lie along the longitudinal axis of the central connecting member <b>24</b>. In this form, the PFO closure device extends longitudinally within a catheter <b>38</b>.
To deploy the PFO closure device <b>18</b>, the catheter <b>38</b> is inserted from the right atrium <b>10</b> through the PFO tunnel, i.e. between septum primum <b>14</b> and septum secundum <b>16</b>, into the left atrium <b>12</b>. As shown in <figref idref="DRAWINGS">FIG. 3</figref><i>a</i>, the grappling hook member <b>20</b> is deployed into the left atrium. Next, as shown in <figref idref="DRAWINGS">FIG. 3</figref><i>b</i>, the catheter <b>38</b> is drawn back into the right atrium and the grappling hooks <b>26</b>, <b>28</b> and <b>30</b> are drawn back and embedded in the left sides of septum primum and septum secundum. The central connecting member <b>24</b> extends at an angle through the PFO tunnel permitting septum primum and septum secundum to be drawn to the closed position and secured by the grappling hooks <b>26</b>, <b>28</b> and <b>30</b>. Finally, as shown in <figref idref="DRAWINGS">FIG. 3</figref><i>c</i>, the catheter <b>38</b> is drawn back to permit the grappling hook member <b>22</b> to deploy, and grappling hooks <b>32</b>, <b>34</b> and <b>36</b> pierce the right side of septum primum and septum secundum.
The grappling hook members <b>20</b> and <b>22</b> may be formed of flexible, spring-like, bioabsorbable polymer material so as to permit movement from the compressed straight shape to the curved hook shapes following deployment from the catheter <b>38</b>. The central connecting member <b>24</b> may also be formed of bioabsorbable material, such as an absorbable suture material, so the device will ultimately leave no foreign substance in either atrium. Alternatively, the grappling hook members <b>20</b> and <b>22</b> may be formed of spring metal or of a shape memory material, such as nitinol. When the PFO closure device is not formed of bioabsorbable material, it is possible to form the device with only the grappling hook member <b>20</b> and a central connecting member <b>24</b> so that the device is repositionable and retrievable. When the device is made of a bioabsorbable material or is not intended to be retrievable, the ends of grappling hooks <b>26</b>, <b>28</b>, <b>30</b>, <b>32</b>, <b>34</b> and <b>36</b> may further include a barb to maintain the device in the septal tissue. In some embodiments, the grappling hook members <b>20</b> and <b>22</b> serve as tissue scaffolds, and are covered with a vascular material, such as polyester, biological tissue, bioresorbable polymer, or spongy polymeric material.
As shown in <figref idref="DRAWINGS">FIG. 3</figref>, the closure device will conform, at least to some extent, to the septal tissue that it compresses. The extent of this conformance depends upon the material from which the device was formed: a device formed of a spring metal or shape memory material will conform to the surrounding septal tissue to a lesser extent than one formed of a flexible, bioabsorbable polymer material.
<figref idref="DRAWINGS">FIG. 4</figref> shows a second embodiment of a PFO closure device with mechanical anchors indicated generally at <b>40</b>. This device, when deployed, forms a ring hook design that terminates in two opposed, pointed ends <b>42</b> and <b>44</b>. The device may be straightened to pass through a catheter <b>38</b>. To deploy the device as shown in <figref idref="DRAWINGS">FIGS. 5</figref><i>a</i>, <b>5</b><i>b </i>and <b>5</b><i>c</i>, the catheter is caused to pierce septum primum <b>14</b> and enter the left atrium where the pointed end <b>42</b> is deployed. Then, as shown in <figref idref="DRAWINGS">FIG. 5</figref><i>b</i>, the catheter is drawn back through septum primum to draw the device through septum primum and embed the pointed end <b>42</b> in the left side of septum secundum. Finally, as shown in <figref idref="DRAWINGS">FIG. 5</figref><i>c</i>, the catheter is withdrawn to fully deploy the PFO closure device and the pointed end <b>44</b> is embedded in the right side of septum secundum to compress septum primum and septum secundum together. As shown in <figref idref="DRAWINGS">FIGS. 4 and 5</figref>, the ring PFO closure device <b>40</b>, when deployed, may include a gap that is slightly smaller than the thickness of septum secundum into which it is embedded. In some embodiments, the opposed ends <b>42</b> and <b>44</b> of the deployed PFO closure device <b>40</b> contact each other or overlap.
As shown in <figref idref="DRAWINGS">FIGS. 13 and 14</figref>, closure device <b>40</b> may take alternative forms. For example, closure devices <b>90</b> and <b>100</b> are formed as partial rings terminating in two pointed ends <b>92</b> and <b>94</b> or <b>102</b> and <b>104</b> and having at least one fold therebetween. Closure devices <b>90</b> and <b>100</b> are deployed in a manner similar to that described above and shown in <figref idref="DRAWINGS">FIG. 5</figref>. When deployed, the pointed ends <b>92</b> and <b>94</b> or <b>102</b> and <b>104</b> puncture the surface of septum secundum exposed in the left atrium and at least one of the folds contacts the surface of septum secundum exposed in the right atrium (<figref idref="DRAWINGS">FIGS. 15</figref><i>a </i>and <b>15</b><i>b</i>). Septum primum and septum secundum are thus compressed between the pointed ends and at least one of the folds of the device (<figref idref="DRAWINGS">FIG. 15</figref><i>c</i>).
Multiple PFO closure devices <b>40</b>, <b>90</b> or <b>100</b> can be inserted until the physician is satisfied with the resultant PFO closure. Again, the PFO closure devices may be formed of flexible, bioabsorbable polymer material, spring metal, other spring-like non-bioabsorbable material, or shape memory material. The choice of material will affect the degree to which the device conforms to the surrounding septal tissue. As shown in <figref idref="DRAWINGS">FIGS. 4</figref>, <b>13</b>, and <b>14</b>, the PFO closure device may be a monolithic structure.
A PFO may also be closed with one or more sutures. As used in the art and indicated in the Figures, “suture” refers to a single connection used to hold two pieces of material or tissue together and need not be a continuous stitch. However, to suture a PFO closed has conventionally required the attachment of septum secundum to septum primum with a continuous stitch. This need for a continuous stitch can be eliminated by implanting sutures across the PFO using implantable suture anchors. As shown in <figref idref="DRAWINGS">FIGS. 6 and 7</figref>, a catheter <b>46</b> is used to puncture septum primum and then septum secundum. In the case of septum primum, the puncture creates a hole through which the catheter can pass; in the case of septum secundum, the puncture may be a depression that does not pass through septum secundum. A single puncture may be made in septum secundum as shown in <figref idref="DRAWINGS">FIGS. 6–8</figref>, or, as subsequently described and shown in <figref idref="DRAWINGS">FIG. 9</figref>, multiple punctures may be made. These punctures are made using a sharp pointed needle tip <b>48</b>. Following puncture to a desired depth, the catheter <b>46</b> surrounding the needle <b>48</b> is withdrawn and the needle component returns (most likely via shape memory) to its predetermined anchor-shape.
The anchors are most likely fabricated from a shape memory alloy, such as nitinol, although they could be made from a flexible, bioabsorbable polymer or a noble metal, each having their own advantage—no long term implant issues with bioabsorbable anchors and excellent radiopacity with anchors fabricated from a noble metal, such as platinum-iridium. The remainder of the suture may be formed of any suitable material, including wire, polymeric materials, and bioabsorbable materials.
The suturing method includes using a standard septal puncture technique to locate and puncture septum primum. Following this, several approaches exist. One would be that the septal puncture needle would be withdrawn from the catheter and the suturing system then delivered through the catheter (the septal needle catheter would maintain position across septum primum during the exchange). Alternatively, a wire could be placed through the septal needle catheter to maintain position and the suture system could be delivered over the wire, or the septal puncture needle could become part of the suture system. Following delivery of the suture system, the proximal end of the suture may then be tied off so as to secure the system in place and keep the PFO closed. As described below for the rivet design suture system and shown in <figref idref="DRAWINGS">FIG. 10</figref><i>c</i>, the proximal end of the suture may be formed into a knot, i.e. the end of the suture may be formed into a structure having a diameter larger than that of the catheter used to puncture septum primum so as to ensure that the suture system remains in place. Other suitable structures for the proximal end of the suture include, but are not limited to, coils, spirals, and other adjustable mechanisms. This structure should apply sufficient compression to hold septum primum and septum secundum together. The structure may be adjustable, such that the level of compression may be altered as necessary. Multiple sutures may be inserted until the physician is satisfied with the PFO closure.
In <figref idref="DRAWINGS">FIG. 8</figref>, a suture <b>50</b> is delivered through the septal needle catheter following the removal of the needle. A suture catheter <b>52</b> enters the left atrium through the septal needle catheter, is pulled back against septum secundum, setting the needle tip(s) <b>54</b> deep within it or through it, if it is thin enough. The tip could be either radiopaque, echogenic, or both, to be visible by x-ray (fluoroscopy) and/or cardiac echo. Once proper position is determined, the constricting system (a hypotube or a series of con-axial hypotubes in the embodiment where multiple needles are simultaneously delivered) is withdrawn, allowing the suture anchor <b>56</b> to form into a pre-determined shape tissue anchor, most likely via shape memory properties. The anchor <b>56</b> on the end of the suture <b>50</b> has been embedded in septum secundum and expands to anchor the suture, which passes through septum primum once the suture catheter is removed. The anchor shape can be one of many different options, including but not limited to a coil, hook, corkscrew, or grappling hook.
In those cases where a true puncture through septum secundum can be made, an anchor can be placed entirely in the right atrium, leaving nothing but suture in the left atrium. These anchors may be short strips or cylindrical rods made from a metallic or polymeric material that is biostable or bioabsorbable, or a piece of swellable foam, such as Ivalon.
In another embodiment, the septal needle catheter crosses septum secundum in multiple locations simultaneously. In this embodiment, the final result, as seen from the left atrium in an end face view of septum primum and septum secundum, would be as shown in <figref idref="DRAWINGS">FIG. 9</figref>, where a plurality of spaced anchors <b>58</b> engage septum secundum.
A rivet design suture system <b>60</b> is shown in <figref idref="DRAWINGS">FIGS. 10</figref><i>a</i>, <b>10</b><i>b </i>and <b>10</b><i>c</i>. Here a suture <b>62</b> and anchor <b>64</b> are contained within a catheter <b>66</b>, which pierces both septum secundum and septum primum. The anchor <b>64</b>, which is formed of a firm material, such as a metal disc, a small hook (such as the shape memory hooks previously described), or a piece of bio-absorbable polymer, is then deployed into the left atrium, and the suture <b>62</b> and catheter <b>66</b> are then pulled back as shown in <figref idref="DRAWINGS">FIG. 10</figref><i>b </i>to compress the two septa together. The suture <b>62</b> can then be knotted with knot <b>68</b>, as shown in <figref idref="DRAWINGS">FIG. 10</figref><i>c</i>, to secure the system <b>60</b> in place to keep the PFO closed, i.e. the end of the suture may be formed into a structure having a diameter larger than that of the catheter used to puncture septum primum so as to ensure that the suture system remains in place. Other suitable structures for the second end of the suture include, but are not limited to, coils, spirals, other adjustable mechanisms. As shown in <figref idref="DRAWINGS">FIG. 10</figref><i>c</i>, this structure should apply sufficient compression to hold septum primum and septum secundum together. The structure may be adjustable, such that the level of compression may be altered as necessary. Multiple rivet systems can be inserted until a physician is satisfied with the PFO closure.
The PFO closure device of the present invention may be formed in a manner to facilitate removal once septum primum and septum secundum are fused. An exemplary removable PFO closure device <b>70</b> is deployed in the manner illustrated by <figref idref="DRAWINGS">FIGS. 11</figref><i>a</i>–<b>11</b><i>d</i>. The PFO closure device <b>70</b> may be delivered by a delivery catheter or sheath <b>72</b> and includes a grappling hook member <b>74</b> joined to a curved arm <b>76</b> by an enlarged tip joinder member <b>78</b>. At least one of the grappling hook member and curved arm of the PFO closure device may be curved relative to the other. An elongate tether <b>80</b> is connected to the tip joinder member <b>78</b> and extends back through the catheter <b>72</b>. The tether <b>80</b> can be coated to minimize trauma to the veins.
To deploy the removable PFO closure device <b>70</b> according to one embodiment of the invention, the grappling hook member <b>74</b> is passed through septum primum <b>14</b> (<figref idref="DRAWINGS">FIG. 11</figref><i>b</i>), and the grappling hook, when free of the catheter, curves in a manner convex relative to the surface of septum secundum and penetrates septum secundum <b>16</b> (<figref idref="DRAWINGS">FIG. 11</figref><i>c</i>). Then, the grappling hook is drawn back toward the catheter by the tether <b>80</b> to apply tension to the tissue causing septum secundum to be drawn into contact with septum primum. Then the curved arm <b>76</b> is deployed (<figref idref="DRAWINGS">FIG. 11</figref><i>d</i>) and curves in a manner concave relative to septum secundum so as to engage septum secundum as the catheter is drawn back. The compressive force applied by the grappling hook and the curved arm hold septum primum and septum secundum tightly together. The grappling hook <b>74</b> and curved arm <b>76</b> are preferably formed of shape memory material, such as nitinol, so that they respond to body temperature when deployed from the catheter <b>72</b> to form the shape shown in <figref idref="DRAWINGS">FIG. 11</figref><i>d. </i>
Once the PFO closure device <b>70</b> is in place, the catheter <b>72</b> is withdrawn and the free end of the tether <b>80</b> is attached to a button subcutaneously and allowed to remain in place for a period of time sufficient to allow the two septa to fuse together. Then the device is pulled through septum primum and into a recovery sheath by means of the tether <b>80</b> and removed.
Contents4
11 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11
Every citation, both waysCites: the store holds 101 of 102
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US9445898B2 | Cited by | United States of America | Applicant |
| US8454656B2 | Cited by | United States of America | Applicant |
| US10058314B2 | Cited by | United States of America | Applicant |
| US9345470B2 | Cited by | United States of America | Applicant |
| US9795482B2 | Cited by | United States of America | Applicant |
| US2007032820A1 | Cited by | United States of America | Pre-grant |
| US2004050393A1 | Cited by | United States of America | Pre-grant |
| US2011092988A1 | Cited by | United States of America | Pre-grant |
| US2012197292A1 | Cited by | United States of America | Pre-grant |
| US2009118726A1 | Cited by | United States of America | Pre-grant |
| US9427220B2 | Cited by | United States of America | Applicant |
| US10433956B2 | Cited by | United States of America | Applicant |
| US2010204730A1 | Cited by | United States of America | Pre-grant |
| US2012296346A1 | Cited by | United States of America | Pre-grant |
| US8777984B2 | Cited by | United States of America | Applicant |
| US12268595B2 | Cited by | United States of America | Applicant |
| US10993807B2 | Cited by | United States of America | Applicant |
| US9980708B2 | Cited by | United States of America | Applicant |
| US11751993B2 | Cited by | United States of America | Applicant |
| US2009093802A1 | Cited by | United States of America | Pre-grant |
| US2007198038A1 | Cited by | United States of America | Pre-grant |
| US2010324595A1 | Cited by | United States of America | Pre-grant |
| US9072603B2 | Cited by | United States of America | Applicant |
| US9861347B2 | Cited by | United States of America | Search report |
| US2008039743A1 | Cited by | United States of America | Pre-grant |
| US2010094337A1 | Cited by | United States of America | Pre-grant |
| US2011208297A1 | Cited by | United States of America | Pre-grant |
| US9737397B2 | Cited by | United States of America | Applicant |
| US10945716B2 | Cited by | United States of America | Applicant |
| US10398435B1 | Cited by | United States of America | Applicant |
| US8333788B2 | Cited by | United States of America | Search report |
| US2008119891A1 | Cited by | United States of America | Pre-grant |
| US2010030328A1 | Cited by | United States of America | Pre-grant |
| US8632585B2 | Cited by | United States of America | Applicant |
| US9220487B2 | Cited by | United States of America | Applicant |
| US10959840B2 | Cited by | United States of America | Applicant |
| US7691112B2 | Cited by | United States of America | Search report |
| US8262724B2 | Cited by | United States of America | Applicant |
| US8579933B2 | Cited by | United States of America | Search report |
| US9138211B2 | Cited by | United States of America | Applicant |
| US9050065B2 | Cited by | United States of America | Applicant |
| US2011208298A1 | Cited by | United States of America | Pre-grant |
| US2006036284A1 | Cited by | United States of America | Pre-grant |
| US10543086B2 | Cited by | United States of America | Applicant |
| US8177836B2 | Cited by | United States of America | Search report |
| US8840655B2 | Cited by | United States of America | Applicant |
| US2008039804A1 | Cited by | United States of America | Pre-grant |
| US8764795B2 | Cited by | United States of America | Applicant |
| US12491346B2 | Cited by | United States of America | Applicant |
| WO2011091184A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| US8454652B1 | Cited by | United States of America | Applicant |
| US9138208B2 | Cited by | United States of America | Applicant |
| US2010152767A1 | Cited by | United States of America | Pre-grant |
| US8357195B2 | Cited by | United States of America | Applicant |
| US2011178534A1 | Cited by | United States of America | Pre-grant |
| US2011092989A1 | Cited by | United States of America | Pre-grant |
| US2010241140A1 | Cited by | United States of America | Pre-grant |
| US8323316B2 | Cited by | United States of America | Search report |
| US8529597B2 | Cited by | United States of America | Search report |
| US8308763B2 | Cited by | United States of America | Applicant |
| US2011178537A1 | Cited by | United States of America | Pre-grant |
| US8784439B1 | Cited by | United States of America | Search report |
| US2005131429A1 | Cited by | United States of America | Pre-grant |
| US9282964B1 | Cited by | United States of America | Applicant |
| CN115243631A | Cited by | China | Search report |
| US7691128B2 | Cited by | United States of America | Search report |
| US2009131925A1 | Cited by | United States of America | Pre-grant |
| EP3278742A2 | Cited by | European Patent Office (EPO) | Applicant |
| US2007032821A1 | Cited by | United States of America | Pre-grant |
| US10098731B2 | Cited by | United States of America | Applicant |
| US8235986B2 | Cited by | United States of America | Applicant |
| US2005101984A1 | Cited by | United States of America | Pre-grant |
| US2011218191A1 | Cited by | United States of America | Pre-grant |
| US2007112338A1 | Cited by | United States of America | Pre-grant |
| US2005119675A1 | Cited by | United States of America | Pre-grant |
| US10743854B2 | Cited by | United States of America | Applicant |
| US3874388A | Cites | United States of America | Applicant |
| US3875648A | Cites | United States of America | Applicant |
| US4006747A | Cites | United States of America | Applicant |
| US4007743A | Cites | United States of America | Applicant |
| US4425908A | Cites | United States of America | Applicant |
| US4696300A | Cites | United States of America | Applicant |
| US4710192A | Cites | United States of America | Applicant |
| US4836204A | Cites | United States of America | Applicant |
| US4902508A | Cites | United States of America | Applicant |
| US4915107A | Cites | United States of America | Applicant |
| US4917089A | Cites | United States of America | Applicant |
| US4956178A | Cites | United States of America | Applicant |
| US5021059A | Cites | United States of America | Applicant |
| US5037433A | Cites | United States of America | Applicant |
| US5041129A | Cites | United States of America | Applicant |
| US5108420A | Cites | United States of America | Applicant |
| US5171259A | Cites | United States of America | Applicant |
| US5192301A | Cites | United States of America | Applicant |
| US5222974A | Cites | United States of America | Applicant |
| US5236440A | Cites | United States of America | Applicant |
| US5257637A | Cites | United States of America | Applicant |
| US5275826A | Cites | United States of America | Applicant |
| US5282827A | Cites | United States of America | Applicant |
| US5284488A | Cites | United States of America | Applicant |
11 members in 6 offices
Priority claims6
| Document | Office | Kind | Date |
|---|---|---|---|
| 34733602 | United States of America | P | |
| 34733602 | United States of America | P | |
| 34180203 | United States of America | A | |
| 60347336 | – | – | – |
| US20020347336P | – | – | – |
| US20030341802 | – | – | – |
Members11
| Document | Office | Kind | |
|---|---|---|---|
| CA2471871A1 | Canada | A1 | |
| WO03059152A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003210510A1 | Australia | A1 | |
| AU2003210510A8 | Australia | A8 | |
| US2003144694A1 | United States of America | A1 | |
| WO03059152A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1471835A2 | European Patent Office (EPO) | A2 | |
| JP2005525843A | Japan | A | |
| US7220265B2This record | United States of America | B2 | |
| US2007265642A1 | United States of America | A1 | |
| EP1471835A4 | European Patent Office (EPO) | A4 |
52 transactions on the USPTO file
Allowed without a rejection on record.
- Non-final rejections
- 0
- Final rejections
- 0
- RCEs
- 0
- Appeals
- 0
Over time
Point at a mark for the transactionTransactions
| Event | Code | |
|---|---|---|
| Expire PatentEXP. | EXP. | |
| Change in Power of Attorney (May Include Associate POA)PA.. | PA.. | |
| Correspondence Address ChangeC.AD | C.AD | |
| Entity status set to undiscounted (initial default setting or status change)BIG. | BIG. | |
| Recordation of Patent Grant MailedPGM/ | PGM/ | |
| Patent Issue Date Used in PTA CalculationAllowedPTAC | PTAC | |
| Electronic ReviewELC_RVW | ELC_RVW | |
| Email NotificationEML_NTF | EML_NTF | |
| Issue Notification MailedAllowedWPIR | WPIR | |
| Dispatch to FDCD1935 | D1935 | |
| Application Is Considered Ready for IssuePILS | PILS | |
| Issue Fee Payment VerifiedN084 | N084 | |
| Workflow - Drawings FinishedDRWF | DRWF | |
| Issue Fee Payment ReceivedIFEE | IFEE | |
| Electronic ReviewELC_RVW | ELC_RVW | |
| Email NotificationEML_NTF | EML_NTF | |
| Mail Notice of AllowanceAllowedMN/=. | MN/=. | |
| Notice of Allowance Data Verification CompletedAllowedN/=. | N/=. | |
| Case Docketed to Examiner in GAUDOCK | DOCK | |
| Case Docketed to Examiner in GAUDOCK | DOCK | |
| Date Forwarded to ExaminerFWDX | FWDX | |
| Response after Ex Parte Quayle ActionA.QU | A.QU | |
| Mail Ex Parte Quayle Action (PTOL - 326)MCTEQ | MCTEQ | |
| Quayle actionCTEQ | CTEQ | |
| Date Forwarded to ExaminerFWDX | FWDX | |
| Response to Election / Restriction FiledELC. | ELC. | |
| Mail Restriction RequirementMCTRS | MCTRS | |
| Restriction/Election RequirementCTRS | CTRS | |
| Reference capture on IDSRCAP | RCAP | |
| Information Disclosure Statement (IDS) FiledM844 | M844 | |
| Information Disclosure Statement (IDS) FiledWIDS | WIDS | |
| Miscellaneous Incoming LetterLET. | LET. | |
| Reference capture on IDSRCAP | RCAP | |
| Information Disclosure Statement (IDS) FiledM844 | M844 | |
| Information Disclosure Statement (IDS) FiledWIDS | WIDS | |
| IFW TSS Processing by Tech Center CompleteTSSCOMP | TSSCOMP | |
| Case Docketed to Examiner in GAUDOCK | DOCK | |
| Reference capture on IDSRCAP | RCAP | |
| Information Disclosure Statement (IDS) FiledM844 | M844 | |
| Information Disclosure Statement (IDS) FiledWIDS | WIDS | |
| Application Dispatched from OIPEOIPE | OIPE | |
| Application Is Now CompleteCOMP | COMP | |
| Reference capture on IDSRCAP | RCAP | |
| Information Disclosure Statement (IDS) FiledM844 | M844 | |
| Information Disclosure Statement (IDS) FiledWIDS | WIDS | |
| Cleared by L&R (LARS)L128 | L128 | |
| IFW Scan & PACR Auto Security ReviewSCAN | SCAN | |
| IFW Scan & PACR Auto Security ReviewSCAN | SCAN | |
| Reference capture on IDSRCAP | RCAP | |
| Information Disclosure Statement (IDS) FiledM844 | M844 | |
| Information Disclosure Statement (IDS) FiledWIDS | WIDS | |
| Initial Exam Team nnIEXX | IEXX |
12 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Lapsed due to failure to pay maintenance feeLapsedFP | FP | |
| Information on status: patent discontinuationPATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362STCH | STCH | |
| Information on status: patent discontinuationPATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362STCH | STCH | |
| Lapse for failure to pay maintenance feesLapsedLAPS | LAPS | |
| Maintenance fee reminder mailedREMI | REMI | |
| AssignmentAS | AS | |
| AssignmentAS | AS | |
| Fee paymentFPAY | FPAY | |
| AssignmentAS | AS | |
| AssignmentAS | AS | |
| Fee payment procedurePAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: LARGE ENTITYFEPP | FEPP | |
| AssignmentAS | AS |
Numbers
- Publication
- 07220265
- Publication, DOCDB
- 7220265
- Publication, EPODOC
- US7220265
- Application
- 10341802
- Application, DOCDB
- 34180203
- Application, EPODOC
- US20030341802
Titles
- English
- Patent foramen ovale (PFO) closure method and device
Patent term adjustment
- A delay
- +764 daysthe office missed an examination deadline
- Applicant delay
- −44 days
- Net adjustment
- 720 days
Classification
- CPC, 8
- A61B17/0057
- A61B17/0644
- A61B17/068
- A61B2017/00575
- A61B2017/00579
- A61B2017/00592
- A61B2017/00615
- A61B2017/00867
- IPC, 7
- A61B17 10
- A61B17 08
- A61B17 00
- A61B
- A61B17 064
- A61B17 068
- A61F2 02
- USPC, 2
- 606139000
- 606151000